在男性和女性人类心脏器官中研究纳米粒子分布和组织结构
Shaun Grumelot1,2, Freyda Mannering3,4,5, Nathan Campbell1,2
1Precision Health Program, Michigan State University, East Lansing, MI 48824, USA.
概括
心肌细胞 (CMs) 是用于心脏治疗中的纳米粒子 (NP) 输送的关键,正如使用人类心脏器官的研究表明的那样. 尽管有机体中基于性别的结构差异存在,但NP分布没有受到影响.
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 纳米医学是一种纳米医学.
背景情况:
- 纳米粒子 (NP) 对心脏应用具有前景,但它们在心脏组织内的相互作用尚未完全理解.
- 人类心脏器官提供了一个模型来研究心脏环境中的NP行为.
研究的目的:
- 为了研究人类心脏器官中的NP分布和细胞局部化.
- 评估器官性对NP生物分布和心脏结构/机制的影响.
主要方法:
- 从诱导的多能干干细胞中获得的人类心脏器官.
- 采用光NP,冷电子显微镜,共聚焦显微镜,超分辨率显微镜,RNA测序和原子力显微镜 (AFM).
- 在NP分布,细胞局部化,结构组织和生物力学方面比较雄性和雌性器官.
主要成果:
- 在富含心肌细胞 (CM) 的区域和细胞外基质中优先积累NP.
- 心肌细胞 (CMs) 的NP同位化明显高于心上细胞.
- 雄性和雌性有机体表现出不同的结构和机械特性,但NP分布和局部化没有显示出基于性别的显著差异.
结论:
- 心肌细胞 (CMs) 对于NP介导的心脏疗法至关重要.
- 心脏器官需要进一步开发,包括免疫成分,以更好地模拟原生心脏组织,用于药物和NP相互作用研究.
相关概念视频
Drug Distribution: Tissue Binding
4.1K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
4.1K
Factors Affecting Drug Distribution: Tissue Permeability
661
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
661
Infertility in Males
571
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
571
Infertility in Females
4.9K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.9K
External Female Genitals
34.1K
The vulva encompasses the external structures of the female reproductive system. At the forefront is the monpubis, a cushion of fatty tissue atop the pubic bone. Once puberty sets in, this area typically grows hair. Extending from just behind the mons pubis are the labia majora (labia = 'lips'; majora = 'larger'), which are larger skin fs olds coated with hair. Nestled within are the labia minora (labia = 'lips'; minora = 'smaller'), which are thinner, more...
34.1K
Disorders of the Female Reproductive System
4.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.5K


